[Chlorazepate and glaucomas].
D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D003009:Clorazepate Dipotassium / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004311:Double-Blind Method; D005901:Glaucoma / Q000139:chemically induced*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D010919:Placebos
D014151:Anti-Anxiety Agents; D010919:Placebos; D003009:Clorazepate Dipotassium
Clorazepate et glaucomes.